Predicting treatment resistance in positive and negative symptom domains from first episode psychosis: Development of a clinical prediction model
Rebecca Lee(Broughton Hospital), Rachel Upthegrove(Birmingham and Solihull Mental Health NHS Foundation Trust), Paris Alexandros Lalousis(King's College London), Laura Bravo-Merodio(University Hospitals Birmingham NHS Foundation Trust), David Fowler(Guardian Chemicals (Canada)), Linda Everard(Birmingham and Solihull Mental Health NHS Foundation Trust), Peter B. Jones(Cambridgeshire and Peterborough NHS Foundation Trust), Swaran P. Singh(University of Warwick), Max Birchwood(University of Warwick), Siân Lowri Griffiths(University of Birmingham), Georgios V. Gkoutos(University Hospitals Birmingham NHS Foundation Trust), Joanne Hodegkins(University of East Anglia), Stephen J. Wood(The University of Melbourne), Tim Amos(University of Bristol), Nick Freemantle(MRC Clinical Trials Unit at UCL)
Cited by 7
Related Papers
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
|Molecular Psychiatry|2021|3.6k
The social determinants of mental health and disorder: evidence, prevention and recommendations
|World Psychiatry|2024|959
The Lancet Psychiatry Commission on youth mental health
|The Lancet Psychiatry|2024|580
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study
|Psychological Medicine|2006|546
Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes
|Archives of General Psychiatry|2006|522